Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates.
Saved in:
| Title: | Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates. |
|---|---|
| Authors: | Issa W; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Aliru M; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX., Zhang S; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX., Gunenc D; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Jiang C; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Qin Q; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Cole S; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Arafat W; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Wang J; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Yang D; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX., Desai N; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX., Garant A; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX., Hannan R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX., Oz OK; Division of Nuclear Medicine, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX., Woldu S; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Roehrborn C; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Courtney K; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Wang AZ; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX., Zhang T; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: tian.zhang@utsouthwestern.edu. |
| Source: | Clinical genitourinary cancer [Clin Genitourin Cancer] 2026 Feb; Vol. 24 (1), pp. 102476. Date of Electronic Publication: 2025 Nov 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
